ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 226 filers reported holding ICU MED INC in Q2 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $9,928,924 | -15.7% | 92,517 | -21.6% | 0.04% | -21.7% |
| Q4 2023 | $11,773,210 | +235.8% | 118,039 | +685.8% | 0.05% | +100.0% |
| Q3 2021 | $3,506,000 | +319.4% | 15,021 | +269.6% | 0.02% | +283.3% |
| Q2 2021 | $836,000 | +61.7% | 4,064 | +68.5% | 0.01% | +50.0% |
| Q4 2020 | $517,000 | -87.9% | 2,412 | -89.7% | 0.00% | -88.6% |
| Q3 2020 | $4,264,000 | +32.5% | 23,330 | +33.6% | 0.04% | -5.4% |
| Q2 2020 | $3,219,000 | +42.4% | 17,467 | +23.3% | 0.04% | -5.1% |
| Q3 2019 | $2,260,000 | -46.3% | 14,162 | -1.2% | 0.04% | -65.5% |
| Q2 2018 | $4,210,000 | +78.2% | 14,337 | +53.1% | 0.11% | +101.8% |
| Q1 2018 | $2,363,000 | +988.9% | 9,364 | +830.8% | 0.06% | +1020.0% |
| Q4 2017 | $217,000 | -71.0% | 1,006 | -76.8% | 0.01% | -73.7% |
| Q2 2017 | $748,000 | -0.1% | 4,334 | -14.7% | 0.02% | +18.8% |
| Q4 2016 | $749,000 | – | 5,081 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
| CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
| PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
| Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
| GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
| Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
| Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
| PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
| DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
| GAM Holding AG | 90,452 | $20,769,000 | 1.05% |